“If we get controlled using medicine and medical technology, then, of course, definitely will be back to our normal,” – said the Minister.
the Minister also reminded that over the last few months acquired a great experience in introducing new products to the medical market.
“We are just two months developed and released to commercial production 30 domestic test-systems. It is an absolute success of the Russian medical science and industry. Informed with such volume and with such speed we’ve never seen,” – said Mikhail Murashko.
the press service of the Ministry of health also noted that Russia already has two registered domestic drug development for the treatment of coronavirus: this Favipiravir and Rokyzana. So, Favipiravir is an antiviral medication of direct action, which fights directly with the virus, twice reducing the time during which patients improved the clinical signs of disease. Rokyzana the drug helps to cope with severe disease develops when the so-called cytokine storm – an excessive inflammatory reaction to the introduction of the virus, which causes damage to tissues and organs, particularly the lung tissue, to a severe course of the infection which may be fatal. Therefore, it is important to prevent the development of the cytokine storm, and if it already has occurred, then suppress, said the Agency.
As reported in the press service of the Ministry, another drug for the treatment of Covid-19 – Levelman – is now undergoing clinical testing in several medical centers of Russia, in particular, in “SMRC them. V. A. Almazov” Ministry Of Health Of Russia. The drug belongs to the group of blockers of receptors for Il 6, and blockade of its action leads to a sharp decrease inflammation in the lung tissue, reduce toxicity, reduce levels of inflammatory markers such as C-reactive protein.
